Parenteral Nutrition Market Size (2024 - 2029)

The parenteral nutrition market is anticipated to experience significant growth, driven by factors such as increased early births, rising chronic diseases, and heightened malnutrition in low- to middle-income countries. The COVID-19 pandemic further accelerated market expansion due to the heightened need for nutritional support in managing infection-related malnutrition. Despite these growth drivers, awareness of parenteral nutrition remains limited in some developing regions, which poses a challenge to market expansion.

Market Size of Parenteral Nutrition Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Parenteral Nutrition Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 7.70 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Parenteral Nutrition Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Parenteral Nutrition Market Analysis

During the time frame of the forecast, the parenteral nutrition market is expected to grow at a CAGR of 7.7%.

The COVID-19 pandemic positively impacted the parenteral nutrition market. Parenteral nutrition plays a major role in treating COVID-19 infection-related malnutrition in patients across the globe. In 2020, the European Society for Clinical Nutrition and Metabolism established a guideline relating to the nutritional management of people infected with the SARS-CoV-2 infection. These guidelines stated that there is an urgent need for nutrition for people suffering from COVID-19 to increase their immunity, which boosted the demand for parenteral nutrition in European countries. The COVID-19 infection resulted in a severe lack of appetite, as well as other symptoms, which led to an increase in loss of muscle mass and deterioration of immune defenses. Hence, clinics and hospitals were focusing more on the provision of nutrition at the point of care. Such developments increased patient demand for and adoption of intravenous nutrition administration.Hence, the COVID-19 pandemic had a significant impact on market growth.

The main things that are driving market growth are the rise in early births, the rise in chronic diseases, and the rise in malnutrition in low- to middle-income countries.

Malnutrition includes not getting enough minerals or vitamins, being undernourished, being overweight or obese, and having a non-communicable disease that is caused by a bad diet. As per the UNICEF data published in July 2022, the prevalence of undernourishment jumped from 8.0% to 9.3% from 2019 to 2020 and rose at a slower pace in 2021 to 9.8%. Additionally, 39 million children under the age of five are overweight, 149 million have stunted growth and development as a result of a chronic lack of nutrient-rich food in their diets, and 45 million suffer from wasting.Hence, the huge burden of underweight children is likely to propel the demand for clinical nutrition and boost market growth in the coming years.

Furthermore, the high rate of premature births contributes to market growth. As per the WHO update of 2021, the rate of preterm birth ranged from 5% to 18% of babies born across 184 countries in 2021. More than 60% of preterm births occurred in Africa and South Asia in the same year and are becoming a global problem. The same source stated that in low-income countries, on average, 12% of babies are born too early, compared to 9% in high-income countries. The 10 countries with the greatest number of preterm births in 2021 include India (9,519,100), China (1,172,300), Nigeria (773,600), Pakistan (748,100), Indonesia (675,700), the United States of America (517,400), Bangladesh (424,100), the Philippines (348,900), the Democratic Republic of the Congo (341,400), and Brazil (279,300). Hence, with the high number of preterm births in various countries, the demand for parenteral nutrition is expected to rise.

But in some developing countries, people don't know much about parenteral nutrition, which slows the growth of the market.

Parenteral Nutrition Industry Segmentation

As per the scope of this report, parenteral nutrition, sometimes called total parenteral nutrition (TPN), is the intravenous administration of nutrition, which may include vitamins, minerals electrolytes, fat, carbohydrate, protein, and other trace elements for those who cannot eat or absorb enough food by tube feeding formula or by mouth to remain healthy. The Parenteral Nutrition Market is Segmented by Nutrition Type (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Others), Patient Type (Newborn, Children, and Adults), End-user (Hospitals, Clinics, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Nutrition Type
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Other Nutrition Types
By Patient Type
Newborn
Children
Adults
By End-user
Hospitals
Clinics
Homecare
Other End-Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Parenteral Nutrition Market Size Summary

The parenteral nutrition market is poised for substantial growth, driven by several key factors including the rise in early births, chronic diseases, and malnutrition, particularly in low- to middle-income countries. The COVID-19 pandemic has further accelerated this growth by highlighting the critical role of parenteral nutrition in managing infection-related malnutrition, thereby increasing its adoption in clinical settings. The demand for intravenous nutrition administration has surged as healthcare providers focus on enhancing patient immunity and preventing muscle mass loss. Despite challenges such as limited awareness in some developing regions, the market is witnessing significant advancements, with major companies introducing innovative products to meet the growing needs of hospitals and healthcare facilities.

North America is expected to hold a significant share of the parenteral nutrition market, with the United States leading due to the high number of hospitalized patients requiring such nutrition. The prevalence of metabolic syndrome and the associated demand for parenteral nutrition are contributing to market expansion in this region. The market is moderately competitive, with key players like Fresenius Kabi AG, B. Braun Melsungen AG, Baxter, ICU Medical, and Abbott dominating the landscape. Strategic developments, such as partnerships and investments in production facilities, are anticipated to further bolster market growth. As the demand for parenteral nutrition continues to rise, particularly in hospital settings, the market is expected to experience robust growth over the forecast period.

Explore More

Parenteral Nutrition Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Rate of Pre-Mature Births

      2. 1.2.2 Increasing Burden of Chronic Conditions

      3. 1.2.3 Rising Prevalence of Malnutrition

    3. 1.3 Market Restraints

      1. 1.3.1 Lack of Awareness in Developing Countries

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Nutrition Type

      1. 2.1.1 Carbohydrates

      2. 2.1.2 Parenteral Lipid Emulsion

      3. 2.1.3 Single Dose Amino Acid Solution

      4. 2.1.4 Trace Elements

      5. 2.1.5 Other Nutrition Types

    2. 2.2 By Patient Type

      1. 2.2.1 Newborn

      2. 2.2.2 Children

      3. 2.2.3 Adults

    3. 2.3 By End-user

      1. 2.3.1 Hospitals

      2. 2.3.2 Clinics

      3. 2.3.3 Homecare

      4. 2.3.4 Other End-Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Parenteral Nutrition Market Size FAQs

The Parenteral Nutrition Market is projected to register a CAGR of 7.70% during the forecast period (2024-2029)

Fresenius Kabi AG, B. Braun Melsungen AG, Baxter, ICU Medical and Option Care Health Inc. are the major companies operating in the Parenteral Nutrition Market.

Parenteral Nutrition Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)